{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:10:30Z","timestamp":1777540230780,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology Major Project of Infectious Diseases","award":["No. 2012ZX10004503-005"],"award-info":[{"award-number":["No. 2012ZX10004503-005"]}]},{"name":"Fujian Technological Innovation Platform Fund","award":["2014Y2101"],"award-info":[{"award-number":["2014Y2101"]}]},{"name":"Science and Technology Plan Program of Xiamen City","award":["3502Z201410045"],"award-info":[{"award-number":["3502Z201410045"]}]},{"name":"Science and Technology Plan Program of Xiamen City","award":["3502Z20131001"],"award-info":[{"award-number":["3502Z20131001"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.virol.2016.01.019","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T13:32:54Z","timestamp":1455629574000},"page":"96-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Modulation of host CD59 expression by varicella-zoster virus in human xenografts in vivo"],"prefix":"10.1016","volume":"491","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenkun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dequan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virol.2016.01.019_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/smim.2001.0293","article-title":"Immune evasion as a pathogenic mechanism of varicella zoster virus","volume":"13","author":"Abendroth","year":"2001","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.virol.2016.01.019_bib2","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/JVI.74.4.1900-1907.2000","article-title":"Modulation of major histocompatibility class II protein expression by varicella-zoster virus","volume":"74","author":"Abendroth","year":"2000","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virol.2016.01.019_bib3","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1128\/JVI.00325-07","article-title":"Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral response","volume":"81","author":"Ambagala","year":"2007","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2016.01.019_bib4","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/eji.1830240722","article-title":"Expression and function of CD59 on colonic adenocarcinoma cells","volume":"24","author":"Bjorge","year":"1994","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.virol.2016.01.019_bib5","doi-asserted-by":"crossref","first-page":"e941","DOI":"10.1111\/j.1365-2230.2009.03350.x","article-title":"Immune evasion during varicella zoster virus infection of keratinocytes","volume":"34","author":"Black","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.virol.2016.01.019_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ijc.2910610420","article-title":"Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity","volume":"61","author":"Brasoveanu","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.virol.2016.01.019_bib7","first-page":"33","article-title":"Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells","volume":"74","author":"Brasoveanu","year":"1996","journal-title":"Lab. Invest."},{"issue":"7","key":"10.1016\/j.virol.2016.01.019_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2004.11.007","article-title":"Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster","volume":"119","author":"Chen","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.virol.2016.01.019_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2567.2006.02467.x","article-title":"Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes","volume":"119","author":"Christmas","year":"2006","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.virol.2016.01.019_bib10","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1086\/517821","article-title":"Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens","volume":"177","author":"Cohen","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2016.01.019_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.febslet.2012.01.039","article-title":"HBXIP upregulates CD46, CD55 and CD59 through ERK1\/2\/NF-kappaB signaling to protect breast cancer cells from complement attack","volume":"586","author":"Cui","year":"2012","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.virol.2016.01.019_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jcp.10050","article-title":"Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells","volume":"190","author":"De Nardo","year":"2002","journal-title":"J. Cell Physiol."},{"issue":"5","key":"10.1016\/j.virol.2016.01.019_bib13","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1074\/jbc.M113.525501","article-title":"NF-kappaB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)\/p300 proteins regulate CD59 protein expression to protect cells from complement attack","volume":"289","author":"Du","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.virol.2016.01.019_bib14","doi-asserted-by":"crossref","first-page":"9034","DOI":"10.1128\/JVI.00711-07","article-title":"Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms","volume":"81","author":"Eisfeld","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.01.019_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fimmu.2013.00291","article-title":"Bioinformatics analysis of the factors controlling type I IFN gene expression in autoimmune disease and virus-induced immunity","volume":"4","author":"Feng","year":"2013","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.virol.2016.01.019_bib16","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1128\/jvi.69.6.3889-3892.1995","article-title":"The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity","volume":"69","author":"Fodor","year":"1995","journal-title":"J. Virol."},{"issue":"5969","key":"10.1016\/j.virol.2016.01.019_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/309633a0","article-title":"Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells","volume":"309","author":"Friedman","year":"1984","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.virol.2016.01.019_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2567.1996.d01-756.x","article-title":"Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes","volume":"89","author":"Gasque","year":"1996","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.virol.2016.01.019_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2990.2011.01167.x","article-title":"Review: The neurobiology of varicella zoster virus infection","volume":"37","author":"Gilden","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"9","key":"10.1016\/j.virol.2016.01.019_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus","volume":"342","author":"Gilden","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"5942","key":"10.1016\/j.virol.2016.01.019_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/306478a0","article-title":"Varicella-zoster virus DNA in human sensory ganglia","volume":"306","author":"Gilden","year":"1983","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virol.2016.01.019_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1011883919058","article-title":"Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia","volume":"23","author":"Gilden","year":"2001","journal-title":"Virus Genes"},{"issue":"5","key":"10.1016\/j.virol.2016.01.019_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1542\/peds.68.5.735","article-title":"Variation on a theme by Fenner: the pathogenesis of chickenpox","volume":"68","author":"Grose","year":"1981","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.virol.2016.01.019_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/infdis\/139.4.432","article-title":"Complement-enhanced neutralizing antibody response to varicella-zoster virus","volume":"139","author":"Grose","year":"1979","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2016.01.019_bib25","first-page":"820","article-title":"Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells","volume":"71","author":"Hakulinen","year":"1994","journal-title":"Lab. Invest."},{"issue":"5","key":"10.1016\/j.virol.2016.01.019_bib26","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1182\/blood-2005-02-0782","article-title":"Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy","volume":"107","author":"Hill","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.virol.2016.01.019_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00665772","article-title":"High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?","volume":"32","author":"Hofman","year":"1994","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.virol.2016.01.019_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI114172","article-title":"Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria","volume":"84","author":"Holguin","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.virol.2016.01.019_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1574-695X.2001.tb00521.x","article-title":"Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP","volume":"31","author":"Huang","year":"2001","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"37","key":"10.1016\/j.virol.2016.01.019_bib30","doi-asserted-by":"crossref","first-page":"27398","DOI":"10.1074\/jbc.M603690200","article-title":"Defining the CD59-C9 binding interaction","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8354","key":"10.1016\/j.virol.2016.01.019_bib31","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(83)90736-5","article-title":"Varicella-zoster virus RNA in human trigeminal ganglia","volume":"2","author":"Hyman","year":"1983","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.virol.2016.01.019_bib32","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/JVI.01956-05","article-title":"Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo","volume":"80","author":"Jones","year":"2006","journal-title":"J. Virol."},{"issue":"Pt 12","key":"10.1016\/j.virol.2016.01.019_bib33","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1099\/vir.0.80406-0","article-title":"Neutralizing human antibodies to varicella-zoster virus (VZV) derived from a VZV patient recombinant antibody library","volume":"85","author":"Kausmally","year":"2004","journal-title":"J. Gen. Virol."},{"issue":"1-3","key":"10.1016\/j.virol.2016.01.019_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2006.06.019","article-title":"Alternative roles for CD59","volume":"44","author":"Kimberley","year":"2007","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2016.01.019_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/tpj.2009.52","article-title":"Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration","volume":"10","author":"Kolev","year":"2010","journal-title":"Pharmacogenomics J."},{"issue":"12","key":"10.1016\/j.virol.2016.01.019_bib36","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.4049\/jimmunol.146.12.4092","article-title":"CD59 functions as a signal-transducing molecule for human T cell activation","volume":"146","author":"Korty","year":"1991","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.virol.2016.01.019_bib37","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1128\/JVI.76.22.11425-11433.2002","article-title":"Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers","volume":"76","author":"Ku","year":"2002","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2016.01.019_bib38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1084\/jem.20040634","article-title":"Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha","volume":"200","author":"Ku","year":"2004","journal-title":"J. Exp. Med."},{"issue":"3-4","key":"10.1016\/j.virol.2016.01.019_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF02919129","article-title":"Herpesviral Fc receptors and their relationship to the human Fc receptors","volume":"11","author":"Litwin","year":"1992","journal-title":"Immunol. Res."},{"issue":"6","key":"10.1016\/j.virol.2016.01.019_bib40","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1128\/jvi.66.6.3643-3651.1992","article-title":"Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI","volume":"66","author":"Litwin","year":"1992","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2016.01.019_bib41","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1007\/s00253-015-6602-5","article-title":"A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine","volume":"99","author":"Liu","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.virol.2016.01.019_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.it.2005.12.008","article-title":"Holding T cells in check--a new role for complement regulators?","volume":"27","author":"Longhi","year":"2006","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.virol.2016.01.019_bib43","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.4049\/jimmunol.175.11.7098","article-title":"Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner","volume":"175","author":"Longhi","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.virol.2016.01.019_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1574-695X.2011.00813.x","article-title":"Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene\/protein expression by oral epithelial cells","volume":"62","author":"Mahtout","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.virol.2016.01.019_bib45","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.166.5.1525","article-title":"Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity","volume":"166","author":"McNearney","year":"1987","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.virol.2016.01.019_bib46","first-page":"609","article-title":"CD2-mediated CD59 stimulation in keratinocytes results in secretion of IL-1alpha, IL-6, and GM-CSF: implications for the interaction of keratinocytes with intraepidermal T lymphocytes","volume":"3","author":"Naderi","year":"1999","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.virol.2016.01.019_bib47","first-page":"129","article-title":"Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin)","volume":"149","author":"Niehans","year":"1996","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.virol.2016.01.019_bib48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0006-291X(89)91743-9","article-title":"Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20","volume":"164","author":"Okada","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.virol.2016.01.019_bib49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"issue":"20","key":"10.1016\/j.virol.2016.01.019_bib50","doi-asserted-by":"crossref","first-page":"12921","DOI":"10.1128\/JVI.79.20.12921-12933.2005","article-title":"T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection","volume":"79","author":"Schaap","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2016.01.019_bib51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/iai.12.3.606-613.1975","article-title":"Neutralizing antibody responses to varicella-zoster virus","volume":"12","author":"Schmidt","year":"1975","journal-title":"Infect. Immun."},{"issue":"18","key":"10.1016\/j.virol.2016.01.019_bib52","doi-asserted-by":"crossref","first-page":"9240","DOI":"10.1128\/JVI.01147-10","article-title":"Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses","volume":"84","author":"Sen","year":"2010","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2016.01.019_bib53","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64604-4","article-title":"Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis","volume":"157","author":"Singhrao","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.virol.2016.01.019_bib54","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.4049\/jimmunol.0804243","article-title":"CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?","volume":"182","author":"Sivasankar","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2016.01.019_bib55","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/JVI.06400-11","article-title":"Varicella-zoster virus inhibition of the NF-kappaB pathway during infection of human dendritic cells: role for open reading frame 61 as a modulator of NF-kappaB activity","volume":"86","author":"Sloan","year":"2012","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2016.01.019_bib56","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.4049\/jimmunol.155.9.4376","article-title":"Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia\/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV)","volume":"155","author":"Spear","year":"1995","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.virol.2016.01.019_bib57","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/eji.1830260719","article-title":"Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells","volume":"26","author":"Spiller","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2016.01.019_bib58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2249.2000.01305.x","article-title":"Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack","volume":"121","author":"Spiller","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2016.01.019_bib59","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.77.1.592-599.2003","article-title":"Complement regulation by Kaposi\u05f3s sarcoma-associated herpesvirus ORF4 protein","volume":"77","author":"Spiller","year":"2003","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2016.01.019_bib60","doi-asserted-by":"crossref","first-page":"e53276","DOI":"10.1371\/journal.pone.0053276","article-title":"Analysis of virion-incorporated host proteins required for herpes simplex virus type 1 infection through a RNA interference screen","volume":"8","author":"Stegen","year":"2013","journal-title":"PLoS One"},{"issue":"Pt 5","key":"10.1016\/j.virol.2016.01.019_bib61","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1099\/vir.0.82394-0","article-title":"Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells","volume":"88","author":"Takemoto","year":"2007","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virol.2016.01.019_bib62","doi-asserted-by":"crossref","first-page":"e16870","DOI":"10.1371\/journal.pone.0016870","article-title":"The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3","volume":"6","author":"Vandevenne","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.virol.2016.01.019_bib63","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1165\/ajrcmb.15.6.8969267","article-title":"Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation","volume":"15","author":"Varsano","year":"1996","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.virol.2016.01.019_bib64","first-page":"542","article-title":"The expression of CD59 in normal human nervous tissue","volume":"82","author":"Vedeler","year":"1994","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.virol.2016.01.019_bib65","doi-asserted-by":"crossref","first-page":"e1004901","DOI":"10.1371\/journal.ppat.1004901","article-title":"Varicella viruses inhibit interferon-stimulated JAK-STAT signaling through multiple mechanisms","volume":"11","author":"Verweij","year":"2015","journal-title":"PLoS Pathog."},{"issue":"14","key":"10.1016\/j.virol.2016.01.019_bib66","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.virol.2016.01.019_bib67","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/1097-0142(19940601)73:11<2808::AID-CNCR2820731125>3.0.CO;2-P","article-title":"Protection of thyroid cancer cells by complement-regulatory factors","volume":"73","author":"Yamakawa","year":"1994","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.virol.2016.01.019_bib68","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0898-6568(03)00054-8","article-title":"Lipopolysaccharide signal transduction in oral keratinocytes\u2013involvement of CD59 but not CD14","volume":"15","author":"Yamamoto","year":"2003","journal-title":"Cell Signal"},{"issue":"20","key":"10.1016\/j.virol.2016.01.019_bib69","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1523\/JNEUROSCI.20-20-07505.2000","article-title":"Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer\u05f3s disease","volume":"20","author":"Yang","year":"2000","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.virol.2016.01.019_bib70","doi-asserted-by":"crossref","first-page":"e1004989","DOI":"10.1371\/journal.ppat.1004989","article-title":"Neuronal subtype and satellite cell tropism are determinants of varicella-zoster virus virulence in human dorsal root ganglia xenografts in vivo","volume":"11","author":"Zerboni","year":"2015","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.virol.2016.01.019_bib71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrmicro3215","article-title":"Molecular mechanisms of varicella zoster virus pathogenesis","volume":"12","author":"Zerboni","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2016.01.019_bib72","doi-asserted-by":"crossref","first-page":"e1000971","DOI":"10.1371\/journal.ppat.1000971","article-title":"Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor","volume":"6","author":"Zhang","year":"2010","journal-title":"PLoS Pathog."},{"issue":"20","key":"10.1016\/j.virol.2016.01.019_bib73","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.1016\/S0021-9258(18)98856-3","article-title":"Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement","volume":"266","author":"Zhao","year":"1991","journal-title":"J. Biol. Chem."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:35:06Z","timestamp":1758587706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682216000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":73,"alternative-id":["S0042682216000222"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2016.01.019","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of host CD59 expression by varicella-zoster virus in human xenografts in vivo","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2016.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}